EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy

Samuel N Lucas iD, Susan N Thomas iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00692 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Samuel N Lucas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States …. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Immunomodulation, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intra- and peritumoral lymphatics and tumor-draining lymph nodes play major roles in mediating the adaptive immune response to cancer immunotherapy. Despite this, current paradigms of clinical cancer management seldom seek to therapeutically modulate tumor-lymphatic immune crosstalk. This review explores recent developments that set the stage for how this regulatory axis can be therapeutically manipulated, with a particular emphasis on tumor-localized immunomodulation. Building on this idea, the nature of tumor-lymphatic immune crosstalk and relevant immunotherapeutic targets and pathways are reviewed, with a focus on their translational potential. Engineered drug delivery systems that enhance intratumoral immunotherapy by improving drug delivery to both the tumor and lymph nodes are also highlighted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyImmunomodulationDrug Delivery SystemsHumansAnimalsLymph NodesTumor Microenvironment

Stichwörter der Autor:innen

cancer immunotherapydrug deliveryimmune crosstalklymphaticssentinel lymph node

Autor:innen und Institutionen

  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States of America.
  • George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States of America.
  • Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, United States of America.
  • Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, United States of America.

ORCID-Profile: Samuel N Lucas, Susan N Thomas

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Lucas, S. N., & Thomas, S. N. (2024). Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00692

Vancouver

Lucas SN, Thomas SN. Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00692

BibTeX
@article{Lucas2024,
  author = {Lucas, Samuel N and Thomas, Susan N},
  title = {Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00692}
}
Kostenlos starten →